KalVista Pharmaceuticals (KALV) Ownership - Who owns KalVista Pharmaceuticals?
KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs... Show more
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. KALV showed earnings on July 10, 2025. You can read more about the earnings report here.